Lates News

Galecto Biotech announced on the Hong Kong Stock Exchange that the Board of Directors hereby announces that Dr. Hans Schambye (founder of Galecto, Chairman and CEO of the Board, and major shareholder of the Company) and Ms. Hoi Ching To (Executive Director and major shareholder of the Company, spouse of Dr. Schambye) have voluntarily committed not to sell (including but not limited to selling or pledging) any shares of the Company held by them or controlled by them directly or indirectly, until the release of the following three clinical data, in order to express their firm confidence in the Company's long-term value and future prospects.